Study: Omicron evades some but not all monoclonal antibodies
Por um escritor misterioso
Descrição
Several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the omicron variant now sweeping across the United States, researchers reported Jan. 19 in the journal Nature Medicine.
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
The ability of therapeutic monoclonal antibodies to neutralize SARS-CoV-2 Omicron BA.2 variant
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies - eBioMedicine
Omicron may sideline two leading drugs against COVID-19
SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex
A COVID treatment wanes: New variants outsmart most monoclonal antibodies : Shots - Health News : NPR
Viruses, Free Full-Text
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
A COVID treatment wanes: New variants outsmart most monoclonal antibodies : Shots - Health News : NPR
Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization
Monoclonal antibodies
SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern - eBioMedicine
de
por adulto (o preço varia de acordo com o tamanho do grupo)
